Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)

ClinicalTrials.gov ID: NCT01279590

Public ClinicalTrials.gov record NCT01279590. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the incidence of statin-associated myalgia (SAM) with treatment with PPD10558 versus atorvastatin in patients previously intolerant to statins. To assess the safety and tolerability of PPD10558 compared to atorvastatin in patients previously intolerant to statins.

Study identification

NCT ID
NCT01279590
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Furiex Pharmaceuticals, Inc
Industry
Enrollment
282 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2011 (Type not available)
Primary completion
Nov 2011 (Actual)
Completion
Nov 2011 (Actual)
Last update posted
Dec 22, 2011

2011

United States locations

U.S. sites
67
U.S. states
29
U.S. cities
63
Facility City State ZIP Site status
Furiex research site Anniston Alabama 36207 —
Furiex research site Phoenix Arizona 85018 —
Furiex research site Phoenix Arizona 85023 —
Furiex research site Huntington Park California 90255 —
Furiex research site Long Beach California 90806 —
Furiex research site Pismo Beach California 93449 —
Furiex research site San Diego California 92103 —
Furiex research site West Lake Village California 91361 —
Furiex research site Colorado Springs Colorado 80907 —
Furiex research site Golden Colorado 80401 —
Furiex research site Hartford Connecticut 06102 —
Furiex research site Boynton Beach Florida 33472 —
Furiex research site Coral Gables Florida 33134 —
Furiex research site Deerfield Beach Florida 33441 —
Furiex research site Fort Lauderdale Florida 33308 —
Furiex research site Gainesville Florida 32605 —
Furiex research site Opa-locka Florida 33054 —
Furiex research site Pembroke Florida 33024 —
Furiex research site Pembroke Florida 33028 —
Furiex research site Sanford Florida 32771 —
Furiex research site West Palm Beach Florida 33401 —
Furiex research site Honolulu Hawaii 96814 —
Furiex Research site Boise Idaho 83704 —
Furiex research site Nampa Idaho 83686 —
Furiex research site Chicago Illinois 60616 —
Furiex research site Mission Kansas 66202 —
Furiex research site Madisonville Kentucky 42431 —
Furiex research site Covington Louisiana 70433 —
Furiex research site Auburn Maine 04210 —
Furiex research site Oxon Hill Maryland 20745 —
Furiex research site Bay City Michigan 48706 —
Furiex research site St Louis Missouri 63117 —
Furiex research site Billings Montana 59101 —
Furiex research site Butte Montana 59701 —
Furiex research site Missoula Montana 59808 —
Furiex research site Omaha Nebraska 68144 —
Furiex research site Great Neck New York 11023 —
Furiex research site Asheville North Carolina 28803 —
Furiex research site Cary North Carolina 27518 —
Furiex research site Charlotte North Carolina 28209 —
Furiex research site Harrisburg North Carolina 28075 —
Furiex research site Hickory North Carolina 28601 —
Furiex research site Hickory North Carolina 28602 —
Furiex research site High Point North Carolina 27262 —
Furiex research site Raleigh North Carolina 27609 —
Furiex research site Raleigh North Carolina 27612 —
Furiex research site Wilmington North Carolina 28401 —
Furiex research site Carlisle Ohio 45005 —
Furiex research site Cincinnati Ohio 45236 —
Furiex research site Columbus Ohio 43213 —
Furiex research site Kettering Ohio 45429 —
Furiex research site Springfield Ohio 45505 —
Furiex research site Altoona Pennsylvania 16602 —
Furiex research site Johnstown Pennsylvania 15905 —
Furiex research site Cumberland Rhode Island 02864 —
Furiex research site East Providence Rhode Island 02914 —
Furiex research site Anderson South Carolina 29621 —
Furiex research site Greenville South Carolina 29605 —
Furiex research site Greer South Carolina 29651 —
Furiex research site Mt. Pleasant South Carolina 29464 —
Furiex research site Pawleys Island South Carolina 29585 —
Furiex research site Bristol Tennessee 37620 —
Furiex research site Tomball Texas 77375 —
Furiex research site Salt Lake City Utah 84124 —
Furiex research site Norfolk Virginia 23502 —
Furiex research site Richmond Virginia 23294 —
Furiex Spokane Washington 99208 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01279590, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 22, 2011 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01279590 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →